Cathay Industrial Biotech (CBIO) Files $200M IPO

July 19, 2011 5:31 PM EDT
Cathay Industrial Biotech Ltd. (Nasdaq: CBIO) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of it's American Depositary Shares, or ADSs. The proposed maximum offering price is $200 million. Cathay filed to list on the New York Stock Exchange under the ticker "CBIO."

The offering is being made through Morgan Stanley, Deutsche Bank, and Jefferies.

Cathay Industrial is a global industrial biotechnology company as measured by production capacity in key biochemical products and a pioneer in the commercialization of bioprocess technologies

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Deutsche Bank, Morgan Stanley, Jefferies & Co

Add Your Comment